Alamandine acts via MrgD to induce AMPK/NO activation against ANG II hypertrophy in cardiomyocytes

Endogenous angiotensin-(1-7)/Mas receptor/NO pathway mediates the cardioprotective effects of pacing postconditioning

(2016) Ala'a Abwainy et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Role of the ACE2/Angiotensin 1–7 Axis of the Renin–Angiotensin System in Heart Failure

(2016) Vaibhav B. Patel et al.   CIRCULATION RESEARCH

Novel RAAS agonists and antagonists: clinical applications and controversies

(2015) Cesar A. Romero et al.   Nature Reviews Endocrinology

Alamandine

(2014) Daniel C. Villela et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Angiotensin-(1–7)

(2014) Robson Augusto Santos   HYPERTENSION

Discovery and Characterization of Alamandine

(2013) Roberto Queiroga Lautner et al.   CIRCULATION RESEARCH

AMPK, insulin resistance, and the metabolic syndrome

(2013) Neil B. Ruderman et al.   JOURNAL OF CLINICAL INVESTIGATION

AMPK signaling pathway is rapidly activated by T3 and regulates the cardiomyocyte growth

(2013) Ana Paula Cremasco Takano et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

AMP-Activated Protein Kinase Regulation and Biological Actions in the Heart

(2012) Vlad G. Zaha et al.   CIRCULATION RESEARCH

Angiotensin-(1-7)-Mediated Signaling in Cardiomyocytes

(2012) Enéas R. M. Gomes et al.   International Journal of Hypertension

AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure

(2011) C. Beauloye et al.   CARDIOVASCULAR RESEARCH

Angiotensin-(1–7) upregulates cardiac nitric oxide synthase in spontaneously hypertensive rats

(2010) María A. Costa et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status

(2010) Terry KW Ma et al.   BRITISH JOURNAL OF PHARMACOLOGY

Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats

(2010) Cheng-Xi Zhang et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Targeting the AMPK pathway for the treatment of Type 2 diabetes

(2009) Benoit Viollet   Frontiers in Bioscience-Landmark

Angiotensin-(1-7) Prevents Cardiomyocyte Pathological Remodeling Through a Nitric Oxide/Guanosine 3′,5′-Cyclic Monophosphate–Dependent Pathway

(2009) Enéas R.M. Gomes et al.   HYPERTENSION

Nuclear Ca2+ regulates cardiomyocyte function

(2008) Silvia Guatimosim et al.   CELL CALCIUM

Molecular Mechanisms Involved in the Angiotensin-(1-7)/Mas Signaling Pathway in Cardiomyocytes

(2008) Marco F. Dias-Peixoto et al.   HYPERTENSION